TY  - JOUR
AU  - Martin de Francisco, Angel Luis
AU  - Gillespie, Iain Andrew
AU  - Gioni, Ioanna
AU  - Floege, Juergen
AU  - Kronenberg, Florian
AU  - Marcelli, Daniele
AU  - Wheelers, David Collins
AU  - Froissart, Marc
AU  - Drueke, Tilman Bernhard
AU  - ARO Steering Comm Cllaborators
PY  - 2016
DO  - 10.1016/j.nefro.2015.10.006
SN  - 0211-6995
UR  - https://hdl.handle.net/10668/25373
T2  - Nefrologia
AB  - Background: Anti-parathyroid treatment initiation and discontinuation are important decisions in chronic haemodialysis (HD) patients, where pill burden is often excessive. The present study aimed to describe secondary hyperparathyroidism (sHPT) drug...
LA  - en
PB  - Soc espanola nefrologia dr rafael matesanz
KW  - Chronic kidney disease
KW  - Chronic kidney disease-mineral and bone disorder
KW  - Haemo dialysis
KW  - Secondary hyperparathyroidism
KW  - Treatment initiation
KW  - Treatment persistence
KW  - Treatment discontinuation
KW  - Mortality risk
KW  - Calcimimetic amg-073
KW  - Cinacalcet
KW  - Association
KW  - Disease
KW  - Paricalcitol
KW  - Phosphorus
KW  - Adherence
KW  - Outcomes
KW  - Hormone
TI  - Anti-parathyroid treatment effectiveness and persistence in incident haemodialysis patients with secondary hyperparathyroidism
TY  - research article
VL  - 36
ER  -